Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 215586
Company: RICONPHARMA LLC

Products on ANDA 215586

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE	HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE	37.5MG;20MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 215586

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
04/06/2022	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/215586Orig1s000ltr.pdf

Therapeutic Equivalents for ANDA 215586

ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE

TABLET;ORAL; 37.5MG;20MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
BIDIL	HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE	37.5MG;20MG	TABLET;ORAL	Prescription	Yes	AB	020727	AZURITY
ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE	HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE	37.5MG;20MG	TABLET;ORAL	Prescription	No	AB	215988	I3 PHARMS
ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE	HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE	37.5MG;20MG	TABLET;ORAL	Prescription	No	AB	215586	RICONPHARMA LLC